Sanara MedTech Inc.

Sanara MedTech Inc. is a medical technology company that develops and sells advanced technologies to improve patient outcomes and reduce healthcare costs in the surgical market. The company's products aim to deliver better clinical results at a lower overall cost for healthcare systems. Sanara MedTech Inc. focuses on being a comprehensive provider of effective surgical solutions and continuously seeks to expand its product offerings for patients needing surgical treatments in the United States. The company primarily markets and sells soft tissue repair and bone fusion products for use in operating rooms or other sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen that assists in managing surgical wounds, and BIASURGE Advanced Surgical Solution, a sterile, no-rinse advanced surgical solution for wound irrigation. Bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive, bioactive, porous implant that supports bony ingrowth, and ALLOCYTE Plus Advanced Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers. Sanara MedTech Inc. also utilizes its in-house research and development team, Rochal Technologies. The company's main source of revenue consistently comes from soft tissue repair and bone fusion products for the surgical market. A smaller portion of revenue is generated from products sold in the post-acute setting. The company previously had a post-acute strategy called Tissue Health Plus (THP), which focused on providing value-based wound care services to payers and risk-bearing entities; however, this program has been discontinued.